Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jie Shen, Margot L Goodkin, Warren Tong & Mayssa Attar. (2017) Ocular pharmacokinetics and tolerability of bimatoprost ophthalmic solutions administered once or twice daily in rabbits, and clinical dosing implications. Clinical Ophthalmology 11, pages 1761-1767.
Read now
Read now
Sarita S Deshpande, Sriram Sonty & Afzal Ahmad. (2017) Evaluating intraocular pressure-lowering solutions for the treatment of open-angle glaucoma: comparison between bimatoprost 0.03% and bimatoprost 0.01% — an observational switch study. Clinical Ophthalmology 11, pages 1371-1376.
Read now
Read now
Daniel Lee, Anand V Mantravadi & Jonathan S Myers. (2017) Patient considerations in ocular hypertension: role of bimatoprost ophthalmic solution. Clinical Ophthalmology 11, pages 1273-1280.
Read now
Read now
Annemie Stevens, Milko E Iliev, Leo de Jong, Ioana Grobeiu & Anton Hommer. (2016) A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension. Clinical Ophthalmology 10, pages 635-641.
Read now
Read now
Articles from other publishers (9)
Kai Man Xu, Ryan Cho & Toby Yiu Bong Chan. (2022) Retrospective Analysis of Switching Bimatoprost 0.01% to Bimatoprost 0.03% in Patients with Various Types of Glaucoma and Ocular Hypertension. Clinical Ophthalmology Volume 16, pages 2385-2390.
Crossref
Crossref
Mariaelena Filippelli, Giuseppe Campagna, Nicola Ciampa, Gaetano Fioretto, Roberta Giannini, Pier Franco Marino, Roberto dell’Omo & Ciro Costagliola. (2022) Ocular Tolerability of Bimatoprost 0.1 mg/mL Preservative-Free versus Bimatoprost 0.1 mg/mL with Benzalkonium Chloride or Bimatoprost 0.3 mg/mL Preservative-Free in Patients with Primary Open-Angle Glaucoma. Journal of Clinical Medicine 11:12, pages 3518.
Crossref
Crossref
Sophie Lemmens, Luca Rossetti, Francesco Oddone, Gordana Sunaric-Mégevand, Anton Hommer, Evelien Vandewalle, Maria Francesca Cordeiro, Andrew McNaught, Giovanni Montesano & Ingeborg Stalmans. (2021) Comparison of preserved bimatoprost 0.01% with preservative-free tafluprost: A randomised, investigator-masked, 3-month crossover, multicentre trial, SPORT II. European Journal of Ophthalmology 32:2, pages 968-975.
Crossref
Crossref
Ajay J Khopade, Arindam Halder, Vinod Burade & Monali Vakharia. (2021) Aqueous humor pharmacokinetics of Benzalkonium chloride free bimatoprost formulated in tight junction modulation technology compared to Benzalkonium chloride preserved bimatoprost 0.01% ophthalmic solution in rabbit eyes. Indian Journal of Clinical and Experimental Ophthalmology 7:2, pages 321-326.
Crossref
Crossref
Jie Shen, Guang Wei Lu & Patrick Hughes. (2018) Targeted Ocular Drug Delivery with Pharmacokinetic/Pharmacodynamic Considerations. Pharmaceutical Research 35:11.
Crossref
Crossref
S. Yu. Petrov, I. V. Kozlova, V. S. Zinina, A. V. Volzhanin & M. V. Kravchik. (2018) Hypotensive efficacy of bimatoprost in monotherapy of primary open-angle glaucoma. Vestnik oftal'mologii 134:5, pages 208.
Crossref
Crossref
Abigail Davis & Michael James Gilhooley. (2016) Glaucoma. InnovAiT: Education and inspiration for general practice 10:6, pages 346-352.
Crossref
Crossref
Monica Samant, Anagha Medsinge & Ken K. Nischal. (2016) Pediatric Glaucoma: Pharmacotherapeutic Options. Pediatric Drugs 18:3, pages 209-219.
Crossref
Crossref
Renato A.S. Germano, Remo SusannaJrJr, Carlos G. De Moraes, Bianca N. Susanna, Carolina N. Susanna & Milena N. Chibana. (2016) Effect of Switching From Latanoprost to Bimatoprost in Primary Open-Angle Glaucoma Patients Who Experienced Intraocular Pressure Elevation During Treatment. Journal of Glaucoma 25:4, pages e359-e366.
Crossref
Crossref